969 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base))

Pill with imprint 969 is Orange, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base). It is supplied by Sun Pharmaceutical Industries Inc..

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 2 mg (base) / 0.5 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for 969

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint

969

Strength

2 mg (base) / 0.5 mg (base)

Color

Orange

Size

6.00 mm

Shape

Round

Availability

Prescription only

Drug Class

Narcotic analgesic combinations

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

3 - Moderate abuse potential

Labeler / Supplier

Sun Pharmaceutical Industries Inc.

National Drug Code (NDC)

62756-0969

Inactive Ingredients

lactose monohydrate, mannitol, povidone, citric acid anhydrous, sodium citrate, FD&C Yellow No. 6, butylated hydroxyanisole, magnesium stearate, acesulfame potassium, corn starch

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "969"

Famotidine

Fluvoxamine Maleate

Sulfinpyrazone

View more

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer